Scilife, an Antwerp, Belgium-based provider of a quality management system for the life sciences sector, received a growth investment from Five Elms Capital.
The amount of the deal was not disclosed.
The company intends to use the funds to consolidate its market presence and improve adoption of its innovative electronic quality management system (eQMS).
Founded in 2017 and led by CEO Filip Heitbrik, Scilife provides a quality management solution featuring comprehensive tools for life sciences company to manage their complex workflows, reducing the burden on quality teams and allowing them to focus on driving value. The company, known for its dynamic Smart Quality Platform, has been instrumental in redefining quality management by integrating advanced data analytics, augmented learning, and gamification. This approach simplifies compliance and positions quality as a key driver of value creation and competitive advantage.
Scilife has been used by hundreds of life sciences companies worldwide, including Novartis, Biocartis, Yusen Logistics, Polpharma, and Pendulum, among others.
FinSMEs
10/06/2024
